Showing results (91-100 of 128) with videos related to
Sort By:
Pageof 13
Lancet (London, England)|February 22, 1997
Randomised controlled trial of CDP571 antibody to tumour necrosis factor-alpha in Crohn's diseaseW A Stack, S D Mann, A J Roy, et al.Journal of Wildlife Diseases|April 26, 2008
Isolation and characterization of Brucella from the lungworms of a harbor porpoise (Phocoena phocoena)C E Dawson, L L Perrett, E J Stubberfield, et al.Patient Preference and Adherence|November 26, 2015
"I wish they could be in my shoes": patients' insights into tertiary health care for type 2 diabetes mellitusJacqueline D Cotugno, Maree Ferguson, Hazel Harden, et al.The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|July 26, 2000
Effect of nortriptyline and paroxetine on extrapyramidal signs and symptoms: A prospective double-blind study in depressed elderly patientsD C Mamo, R A Sweet, B H Mulsant, et al.Applied Optics|September 21, 2007
Relaxing the alignment and fabrication tolerances of thin annular folded imaging systems using wavefront codingEric J Tremblay, Joel Rutkowski, Inga Tamayo, et al.The Journal of Clinical Psychiatry|November 6, 2002
Risk factors for falls during treatment of late-life depressionJin H Joo, Eric J Lenze, Benoit H Mulsant, et al.Annals of Clinical and Translational Neurology|March 21, 2022
Prognostic value of serum/plasma neurofilament light chain for COVID-19-associated mortalityRuturaj R Masvekar, Peter Kosa, Kimberly Jin, et al.Journal of Clinical Psychopharmacology|August 1, 1992
Nortriptyline and weight change in depressed patients over 60C F Paradis, J A Stack, C J George, et al.The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|May 10, 2005
Accelerating symptom-reduction in late-life depression: a double-blind, randomized, placebo-controlled trial of sleep deprivationCharles F Reynolds, Gwenn S Smith, Mary Amanda Dew, et al.Pageof 13